Cai Ying, Wang Ning, Wu Xiaomei, Zheng Kai, Li Yan
Department of Infectious Diseases, No. 324 Hospital of PLA, Chongqing, 400020 China.
Medical Research Center, Southwest Hospital, Third Military Medical University, Chongqing, 400038 China.
Springerplus. 2016 Aug 12;5(1):1340. doi: 10.1186/s40064-016-3003-x. eCollection 2016.
Although the drug-induced mutations of HBV have been ever documented, the evolutionary mechanism is still obscure. To deeply reveal molecular characters of HBV evolution under the special condition, here we made a comprehensive investigation of the molecular variation of the 3432 wild-type sequences and 439 YMDD variants from HBV genotype A, B, C and D, and evaluated the co-variant patterns and the frequency distribution in the different YMDD mutation types and genotypes, by using the naïve Bayes classification algorithm and the complete induction method based on the comparative sequence analysis. The data showed different compensatory changes followed by the rtM204I/V. Although occurrence of the YMDD mutation itself was not related to the HBV genotypes, the subsequence co-variant patterns were related to the YMDD variant types and HBV genotypes. From the hierarchy view, we clarified that historical mutations, drug-induced mutation and compensatory variances, and displayed an inter-conditioned relationship of amino acid variances during multiple evolutionary processes. This study extends the understanding of the polymorphism and fitness of viral protein.
尽管药物诱导的乙肝病毒(HBV)突变已有文献记载,但其进化机制仍不清楚。为深入揭示特殊条件下HBV进化的分子特征,我们对来自HBV A、B、C和D基因型的3432个野生型序列和439个YMDD变异体的分子变异进行了全面研究,并基于比较序列分析,采用朴素贝叶斯分类算法和完全归纳法,评估了不同YMDD突变类型和基因型中的共变异模式及频率分布。数据显示,rtM204I/V之后出现了不同的补偿性变化。虽然YMDD突变本身的发生与HBV基因型无关,但后续的共变异模式与YMDD变异体类型和HBV基因型有关。从层次角度来看,我们阐明了历史突变、药物诱导突变和补偿性变异,并展示了多个进化过程中氨基酸变异的相互制约关系。本研究扩展了对病毒蛋白多态性和适应性的理解。